ASX - By Stock
|
RAP |
Re:
US Clinical- Individual digital cough sound
|
|
Deadant
|
9 |
4.5K |
15 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
9
|
4.5K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
US Clinical- Individual digital cough sound
|
|
Deadant
|
9 |
4.5K |
11 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
9
|
4.5K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
US Clinical- Individual digital cough sound
|
|
Deadant
|
9 |
4.5K |
2 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
9
|
4.5K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
US Clinical- Individual digital cough sound
|
|
Deadant
|
9 |
4.5K |
3 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
9
|
4.5K
|
3
|
|
ASX - By Stock
|
RAP |
US Clinical- Individual digital cough sound
|
|
Deadant
|
9 |
4.5K |
31 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
9
|
4.5K
|
31
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Deadant
|
35 |
13K |
0 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
35
|
13K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Deadant
|
35 |
13K |
1 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
35
|
13K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Deadant
|
35 |
13K |
1 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
35
|
13K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Deadant
|
35 |
13K |
2 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
35
|
13K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Deadant
|
35 |
13K |
10 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
35
|
13K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
Deadant
|
12 |
5.1K |
0 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
12
|
5.1K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Results and Investor Conference Call Notification
|
|
Deadant
|
12 |
5.1K |
8 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
12
|
5.1K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Deadant
|
3.3K |
2.5M |
6 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
6
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Deadant
|
3.3K |
2.5M |
18 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
18
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Deadant
|
3.3K |
2.5M |
3 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
3
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Deadant
|
3.3K |
2.5M |
9 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
3.3K
|
2.5M
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Competitive Threat to ResApp
|
|
Deadant
|
120 |
35K |
5 |
12/04/21 |
12/04/21 |
ASX - By Stock
|
120
|
35K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Covid test
|
|
Deadant
|
53 |
20K |
10 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
53
|
20K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Covid test
|
|
Deadant
|
53 |
20K |
8 |
04/04/21 |
04/04/21 |
ASX - By Stock
|
53
|
20K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Covid test
|
|
Deadant
|
53 |
20K |
5 |
03/04/21 |
03/04/21 |
ASX - By Stock
|
53
|
20K
|
5
|
|
ASX - By Stock
|
RAP |
Covid test
|
|
Deadant
|
53 |
20K |
18 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
53
|
20K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
what is it going to take to see .30 again ?
|
|
Deadant
|
50 |
18K |
3 |
26/03/21 |
26/03/21 |
ASX - By Stock
|
50
|
18K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
|
|
Deadant
|
106 |
31K |
0 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
106
|
31K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
|
|
Deadant
|
106 |
31K |
10 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
106
|
31K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Clinical study to develop COVID-19 screening test
|
|
Deadant
|
118 |
37K |
2 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
118
|
37K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
|
|
Deadant
|
106 |
31K |
6 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
106
|
31K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Change of Director's Interest Notice - Chris Ntoumenopoulos
|
|
Deadant
|
106 |
31K |
0 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
106
|
31K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
some competition for RAP
|
|
Deadant
|
20 |
6.2K |
5 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
20
|
6.2K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Resignation of Joint Company Secretary
|
|
Deadant
|
16 |
6.2K |
6 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
16
|
6.2K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
My thoughts
|
|
Deadant
|
118 |
21K |
2 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
118
|
21K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
British journal of GPs ...pneumonia
|
|
Deadant
|
28 |
10K |
3 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
28
|
10K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pre-Submission package lodged with the US FDA
|
|
Deadant
|
199 |
56K |
10 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
199
|
56K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
The smartphone recordings of cough sounds 2 (SMARTCOUGH-C 2) trial design
|
|
Deadant
|
2 |
1.5K |
22 |
06/02/21 |
06/02/21 |
ASX - By Stock
|
2
|
1.5K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives $801,738 R&D tax incentive refund and grant
|
|
Deadant
|
76 |
25K |
11 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
76
|
25K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Deadant
|
314 |
83K |
11 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
314
|
83K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Deadant
|
314 |
83K |
0 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
314
|
83K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
4 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
79
|
29K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
0 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
79
|
29K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
10 |
26/01/21 |
26/01/21 |
ASX - By Stock
|
79
|
29K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
4 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
79
|
29K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
5 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
79
|
29K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
5 |
24/01/21 |
24/01/21 |
ASX - By Stock
|
79
|
29K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
How Phenix and Coviu Integration is doing?
|
|
Deadant
|
42 |
16K |
9 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
42
|
16K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
How Phenix and Coviu Integration is doing?
|
|
Deadant
|
42 |
16K |
10 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
42
|
16K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp appoints VP, Commercial to progress growth strategy
|
|
Deadant
|
231 |
81K |
4 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
231
|
81K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp appoints VP, Commercial to progress growth strategy
|
|
Deadant
|
231 |
81K |
28 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
231
|
81K
|
28
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp appoints VP, Commercial to progress growth strategy
|
|
Deadant
|
231 |
81K |
2 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
231
|
81K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
3 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
79
|
29K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
RAP - dec 2020 qtr revenue and share price prediction (
|
|
Deadant
|
79 |
29K |
3 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
79
|
29K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
How Phenix and Coviu Integration is doing?
|
|
Deadant
|
42 |
16K |
14 |
17/01/21 |
17/01/21 |
ASX - By Stock
|
42
|
16K
|
14
|
|